MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'diet pill'. Sat, 03 Sep 2011 02:49:47 +0100 http://www.medworm.com/index.php?rid=4780486&cid=t_125877_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FIjq9ZMQ6Rf4%2F Anxious to win FDA approval for its Qnexa diet pill, Vivus has come up with an unsual fallback position to overcome safety issues that have so far scuttered agency endorsement. If the results of a planned teratogenicity study are inadequate to win over regulators, the beleaguered little drugmaker plans to seek a limited indication. Very limited. This would involve allowing docs to prescribe the diet pill to “only men and women of non-child bearing potential” (read here). This might seem counterintuitive. After all, diet pills are widely sought by countless women who are still capable of conceiving. For instance, Leerink Swann analyst Steve Yoo estimates in an investor note this morning that about 50 percent of the “likely market could fall into the women of childbearing a... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4780486 Tue, 03 May 2011 13:07:13 +0100 4780486 http://www.medworm.com/index.php?rid=4715016&cid=t_125877_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FYiEPmFQ6yMo%2F And so another work week will soon draw to a close. This means, of course, the time has come to daydream about weekend plans. Our agenda includes spring cleaning, taking one of our short people to a soccer match and catching up on some sleep. What about you? Anything special planned? A walk in the park? Reaching out to an old friend? Maybe planning the rest of your life? Whatever you do, have a great time. Meanwhile, here are some tidbits. Catch you soon… EU Backs Boehringer Pradaxa Stroke Prevention Drug (Reuters) US Will Negotiate Medicare Drug Prices: Obama (Pharma Times) EU OKs Bydureon Diabetes Med From Lilly & Amylin (Reuters) Genzyme MS Drug Shows Promising Five-Year Results (Mass High Tech) Glaxo To Sell Plant And Eliminate 250 Jobs (Memphis Business Journal) Glaxo To Se... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4715016 Fri, 15 Apr 2011 11:33:47 +0100 4715016 http://www.medworm.com/index.php?rid=4715020&cid=t_125877_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FcEBOhpGUe_M%2F For the second time in five years, Public Citizen is petitioning the FDA to ban the Xenical prescription diet pill sold by Roche, which is also marketed in a lower-dose, over-the-counter version as Alli by GlaxoSmithKline. The latest move comes after a report earlier this week that linked the drug to kidney stones and pancreatic damage. The watchdog group identified 47 cases of acute pancreatitis and 73 kidney stones among patients taking either the prescription version or the over-the-counter form. Last year, the FDA added warnings to Xenical and Alli about rare reports of liver damage - 12 reports of severe liver toxicity associated with Xenical and one domestic case for Alli. Two of the patients died of liver failure and three required liver transplants. Public Citizen wants the manufac... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4715020 Thu, 14 Apr 2011 14:49:30 +0100 4715020 http://www.medworm.com/index.php?rid=4709424&cid=t_125877_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FpR8BdZuodiU%2F Hello, everyone, and nice to see you again. A spot of rain is falling on the Pharmalot corporate campus, but as you know, our spirits are as sunny as ever and reinforced by a bit of wisdom from the Morning Mayor: ‘Every brand new day should be unwrapped like a precious gift.’ So while we down our cup of stimulation, we present the news of the world in hopes this will help you cope with those meetings and deadlines. Have a great day and give someone a big smile… BioSante Says FDA Accepts Filing For Male Testerone Gel (Reuters) Merck To Outsource Work Done At Pennsylvania Plant (The Daily Item) Novartis Drug Wins FDA Panel OK For Rare Pancreatic Tumors (Bloomberg News) Pfizer Drug Wins FDA Committee Backing For Pancreatic Cancer (Bloomberg News) Roche’s Xenical Diet P... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4709424 Wed, 13 Apr 2011 12:12:07 +0100 4709424 http://www.medworm.com/index.php?rid=3753739&cid=t_125877_83_f&fid=34856&url=http%3A%2F%2Finsidesurgery.com%2F2010%2F07%2Fexperimental-diet-pill-shows-promise%2F The experimental diet pill lorcaserin was shown to be beneficial in helping patients lose weight and did not show major serious side effects in a article published in the July 15, 2010 issue of the New England Journal of Medicine. (Source: Inside Surgery) Inside Surgery blogs http://www.medworm.com/rss/comments.php?id=3753739 Thu, 15 Jul 2010 02:12:40 +0100 3753739 http://www.medworm.com/index.php?rid=3603874&cid=t_125877_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fl9IEbYtopHU%2F The FDA has issued a warning that the popular Alli diet pill may cause a severe liver injury. The move comes three years after GlaxoSmithKline began marketing Alli as an over-the-counter version of Xenical, a prescription drug marketed by Roche (background) which, you may recall, fared poorly due to side effects such as leakages and oily discharges. Both contain the active ingredient known as orlistat. In explaining its decision, the FDA said it identified 13 cases of severe liver injury, with 12 coming from outside the US. The one case in the US involved Alli. Two patients died from liver failure and three required transplantation, although the agency emphasized that a cause-and-effect relationship has not been established (you can read more here). (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3603874 Wed, 26 May 2010 17:43:13 +0100 3603874 http://www.medworm.com/index.php?rid=1764071&cid=t_125877_151_f&fid=35823&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FAddictionInbox%2F%7E3%2F382508632%2Fdrug-for-cocaine-addicts-causes-weight.html Is Vigabatrin the next big diet pill?The U.S. Department of Energy's Brookhaven National Laboratory announced that obese rats lost weight on the experimental anti-cocaine drug vigabatrin, reinforcing the idea that certain forms of obesity--particularly binge eating--result from the same kinds of neurotransmitter disturbances that underlie vulnerability to addictive drugs like cocaine.Amy DeMarco, lead author of the study, said in a press release from Brookhaven that the results "appear to demonstrate that vigabatrin induced satiety in these animals."Earlier, the U.S. Food and Drug Administration (FDA) had given Fast Track designation to vigabatrin, an anticonvulsant, for evaluation as an anti-craving drug for cocaine and methamphetamine addiction. If successful, it would be the first medic... Addiction Inbox blogs http://www.medworm.com/rss/comments.php?id=1764071 Wed, 03 Sep 2008 17:17:00 +0100 1764071 http://www.medworm.com/index.php?rid=682754&cid=t_125877_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F06%2F18%2Fbeware-the-wrath-of-alli%2F Filed under: Type 2, Adult Onset, Diet, Drugs, Research, Products, SupportIt's here and you should know all about the first over the counter FDA approved weight loss pill, alli. A word of caution: if you're a cheater on your diets - it seems like Glaxo is raising red flags before things get messy. No seriously, read on to find out what I'm talking about. Alli works by preventing your body from absorbing some of the fat you eat. It attaches to natural enzymes in the digestive system and prevents absorption of fat from the foods you eat. Undigested fat cannot be absorbed and passes through the body naturally. I know you're wondering about side effects, so here you go: the most common treatment effects (as they're eloquently called) come from eating meals with too much fat. The unabsorbed ex... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=682754 Mon, 18 Jun 2007 04:00:00 +0100 682754